# Combination Therapy of Umbilical Cord Blood and Erythropoietin for Stroke Paients

> **NCT04013646** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Bundang CHA Hospital** · enrollment: 24 (estimated)

## Conditions studied

- Stroke
- Umbilical Cord Blood
- Erythropoietin
- Safety
- Treatment Outcome

## Interventions

- **DRUG:** Umbilical cord blood infusion
- **DRUG:** Erythropoietin injection
- **DRUG:** Placebo umbilical cord blood infusion
- **DRUG:** Placebo erythropoietin injection
- **PROCEDURE:** Active rehabilitation

## Key facts

- **NCT ID:** NCT04013646
- **Lead sponsor:** Bundang CHA Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-02
- **Primary completion:** 2020-11-02
- **Final completion:** 2021-11-02
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2020-11-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04013646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04013646, "Combination Therapy of Umbilical Cord Blood and Erythropoietin for Stroke Paients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04013646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*